Global Biochip Markets: Microarrays and Lab-on-a-Chip

Report Highlights

The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.

Report Includes

• An overview of the global market for current and emerging biochip technologies.
• Analyses of global market trends, with data from 2014, 2015, and projections of CAGRs through 2020.
• Characterizations of biochip markets by type (DNA microarray, protein microarray, emerging microarray, and lab-on-a-chip); by function (gene expression, genotyping, micro-RNA, epigenetic, sequence capture); and by end-user (research-and-development tools, drug discovery and development, diagnostics, sequencing, and applied).
• A focused study on the market for biochip-based diagnostics products, a major future segment for biochips.
• Discussion of the main commercial biochip technologies and the commercial potential of the key market segments.
• Examination of the factors that influence the market, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, and customer needs.
• Patent analysis.
• Profiles of major players in the industry.

Report Scope

The study scope includes the major biochip platforms, including DNA and protein microarrays, tissue/cell and glycomics microarrays, LOAC products and NGS. Each platform is analyzed to determine its market status, impact on future market segments, and forecast growth from 2015 through 2020. Technology status and market driving forces are discussed, as well as influencing market factors like industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs and competitive trends.

In addition to the main LOAC, microarray and sequencing industries, BCC Research profiles several specialized biochip industry segments including the following: DNA analyzers, ion channel screening, digital PCR, label-free detection, nanoarray, peptide microarray, antibody microarray, antibody reagents, multiplex protein diagnostics, circulating tumor cell, prenatal screening, point of care CD4 counting and China’s biochips industries.

Applications for biochips-based diagnostics are highlighted in this report — particularly cancer diagnostics — as well as new data about biochip substrate types.

This BCC Research report also analyzes patent data for each biochip type. The industry has grown significantly since the last report, and nearly 300 companies are profiled in our analysis.

The table below highlights the scope of this report and identifies areas that were not analyzed.

Not included in the report are bioinformatics products and revenues and service revenues associated with biochips and chemical reagents associated microarrays and LOAC devices.

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.